GSK
(NYSE) GSK
GSK Financials at a Glance
Market Cap
$105.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
£32.78B
Net Income (TTM)
£5.83B
EPS (TTM)
$3.82
P/E Ratio
13.61
Dividend
$1.80
Beta (Volatility)
0.25 (Low)
Dividend
$1.80
Beta (Volatility)
0.25 (Low)
Price
$52.77
Volume
184,336
Open
$53.02
Price
$52.77
Volume
184,336
Open
$53.02
Previous Close
$52.77
Daily Range
$52.31 - $53.07
52-Week Range
$35.45 - $61.70
Estimated Earnings Date
Jul 28, 2026
Dividend
$1.80
Beta (Volatility)
0.25 (Low)
Price
$52.77
Volume
184,336
Open
$53.02
Previous Close
$52.77
Daily Range
$52.31 - $53.07
52-Week Range
$35.45 - $61.70
Estimated Earnings Date
Jul 28, 2026
GSK News
GSK: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GSK
Industry
Pharmaceuticals
Sector
Health CareEmployees
66,841
CEO
Luke Miels, MBA
Website
www.gsk.comHeadquarters
Brentford, TW8 9GS, GB
GSK Financials
Key Financial Metrics (TTM)
Gross Margin
72.74%
Operating Margin
22.34%
Net Income Margin
17.78%
Return on Equity
35.78%
Return on Capital
24.50%
Return on Assets
9.27%
Earnings Yield
7.35%
Dividend Yield
3.40%
Payout Ratio
44.52%
Stock Overview
Market Cap
$105.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
2.00B
Volume
184.34K
Avg. Volume
3.87M
Financials (TTM)
Gross Profit
£23.83B
Operating Income
£8.42B
EBITDA
£11.27B
Operating Cash Flow
£8.30B
Capital Expenditure
-£2.06B
Free Cash Flow
£6.24B
Cash & ST Invst.
£4.54B
Total Debt
£25.13B
GSK Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
£7.63B
+1.5%
Gross Profit
£5.75B
+3.1%
Gross Margin
75.42%
N/A
Market Cap
$105.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.54M
N/A
Employees
68,629
N/A
Net Income
£1.74B
+7.0%
EBITDA
£2.77B
-10.3%
Quarterly Fundamentals
Total Cash
£4.54B
-21.6%
Total Debt
£25.13B
+5.6%
Accounts Receivable
£10.47B
+8.1%
Inventory
£8.12B
+4.8%
Long Term Debt
£18.48B
-13.1%
Short Term Debt
£6.65B
+163.2%
Return on Assets
9.27%
N/A
Return on Invested Capital
18.11%
N/A
Free Cash Flow
£698.00M
+0.1%
Operating Cash Flow
£1.14B
-0.3%